The feasibility clinical study is designed to evaluate PRIMA sub-retinal implant in patients with atrophic dry age-related macular degeneration
Researchers identify transneuronal spread of Tau protein in Alzheimer's disease
Study in metastatic triple-negative breast cancer presented at San Antonio Breast Cancer Symposium
University of Manchester and Orchard Therapeutics team up to treat Sanfilippo syndrome
Crown Bioscience and Data Sciences International partner to advance metabolic disease research
Trial will analyze breath biomarkers to improve understanding of the treatment effects of a novel GSK pipeline drug candidate for COPD
Multi-center observational study demonstrated a 24% reduction in biopsy procedures performed for men tested with phi compared to historical practice
A specific immunotherapy that could be used to stop the destruction of pancreatic cells in early stage diabetes
Helperby's ARB technology rejuvenates existing antibiotics to outsmart antibiotic resistance
15 Tesla ultra-high field pre-clinical MRI system to further accelerate multi-disciplinary research
Learn how scientists have developed an innovative hepatic model to better predict hepatotoxicity and discover the secrets to cell culture success at PhoenixSongs Biologicals
IntraStem intracellular delivery system offers possibility of increasing MSC transfection rates by up to 200%
Painful side effects from cancer medicines could be tackled with a drug that eases the effects of jetlag, research suggests
Relvar Ellipta was superior to usual care treatment in improving asthma control for patients in Salford Lung Study
Program is 'invaluable' for scientists needing to make informed purchasing decisions for their lab
Discover how a research group at the University of Geneva, Switzerland, is using an innovative approach to accelerate therapeutics through the drug development process
Pre-Term Preeclampsia Project “ASPRE” Study Utilized PerkinElmer’s DELFIA Xpress PlGF 1-2-3 Assay to Identify Women who Would Benefit from Low-Dose Aspirin
7 UK universities to acquire Helios mass cytometry systems to drive life-changing health discoveries
AEOL 10150 is currently the only drug being developed by BARDA to address the delayed effects of radiation exposure
